If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Wiley-Blackwell

Related content
Volume 10, Supplement 1, March 2004

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content Introduction
pp. vi-vi(1)
Author: Nord, Carl Erik

Favourites:Add to Favourites

Free Content History of the development of azole derivatives
pp. 1-10(10)
Author: Maertens, J. A.

Favourites:Add to Favourites

Free Content Infections due to emerging and uncommon medically important fungal pathogens
pp. 48-66(19)
Authors: Walsh, T. J.; Groll, A.; Hiemenz, J.; Fleming, R.; Roilides, E.; Anaissie, E.

Favourites:Add to Favourites

Free Content Human fusariosis
pp. 67-75(9)
Authors: Dignani, M. C.; Anaissie, E.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Antifungal prophylaxis with azole derivatives
pp. 86-95(10)
Authors: Castagnola, E.; Machetti, M.; Bucci, B.; Viscoli, C.

Favourites:Add to Favourites

Free Content Oral versus intravenous therapy in the treatment of systemic mycosis
pp. 96-106(11)
Authors: Perea, J. R. Azanza; Díaz de Rada, B. Sádaba; Quetglas, E. García; Juarez, M. J. Muñóz

Favourites:Add to Favourites

Free Content Voriconazole—a new therapeutic agent with an extended spectrum of antifungal activity
pp. 107-117(11)
Authors: Donnelly, J. P.; De Pauw, B. E.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more